Leo Pharma To Highlight Data At 28th Congress Of The European Academy Of Dermatology Eadv Business Wire
Emj Dermatology 7 1 2019
Eadv 2019 Congress In Dermatology And Venereology Official Website
Tildrakizumab In Patients With Moderate To Severe Psoriasis Post Hoc Analyses On Efficacy Time To Relapse Long Term Safety In Elderly Population And Predictability From The Resurface 1 And Resurface 2 Phase Iii Clinical Trials
Eadv European Academy Of Dermatology And Venereology Via Serafino Balestra 22 B Lugano 2020